Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1<alpha> signaling pathway-Reference-Cited by-同舟云学术

Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway

Published:2019-07 Issue:1 Volume:380 Page:36-46
ISSN:0014-4827
Container-title:Experimental Cell Research
language:en
Short-container-title:Experimental Cell Research

Author:

Liu Pengfei,Gu Yue,Luo Jie,Ye Peng,Zheng Yaguo,Yu Wande,Chen Shaoliang

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cell Biology

Reference36 articles.

1. Microvessel mechanobiology in pulmonary arterial hypertension: cause and effect;Bloodworth;Hypertension,2015

2. Modern age pathology of pulmonary arterial hypertension;Stacher;Am. J. Respir. Crit. Care Med.,2012

3. Management of pulmonary arterial hypertension;McLaughlin;J. Am. Coll. Cardiol.,2015

4. Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension;Piao;J. Mol. Med.,2013

5. From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension;Paulin;J. Mol. Med.,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluorinated perhexiline derivative attenuates vascular proliferation in pulmonary arterial hypertension smooth muscle cells;Vascular Pharmacology;2024-09

2. A Lifelike guided journey through the pathophysiology of pulmonary hypertension—from measured metabolites to the mechanism of action of drugs;Frontiers in Cardiovascular Medicine;2024-05-23

3. BMPR2 Loss Activates AKT by Disrupting DLL4/NOTCH1 and PPARγ Signaling in Pulmonary Arterial Hypertension;International Journal of Molecular Sciences;2024-05-15

4. Disruption of DLL4/NOTCH1 Causes Dysregulated PPARγ/AKT Signaling in Pulmonary Arterial Hypertension;2024-02-02

5. Hydroxy-Safflower Yellow A Mitigates Vascular Remodeling in Rat Pulmonary Arterial Hypertension;Drug Design, Development and Therapy;2024-02